Award Winner (Distinguished Service Award) 2023: Toni Manzano
Back to Honor Awards PageToni Manzano
Aison
My journey with the PDA began 7 years ago, with a deep-rooted passion for advancing the pharmaceutical industry. I was inspired to become a member of PDA due to its reputation for fostering collaboration, innovation, and continuous improvement within the pharma community. The association's commitment to sharing knowledge and driving progress resonated with my own professional values and aspirations.
From the outset, PDA has provided me with invaluable opportunities to collaborate on different initiatives aimed at enhancing the drug manufacturing process. One of the most rewarding aspects of my membership has been the ability to work alongside industry leaders and experts who are equally dedicated to elevating the standards of our field on hands-on projects and papers.
As digitalization began to play an increasingly pivotal role in our industry, I found myself at the forefront of several PDA initiatives focused on integrating digital technologies into manufacturing processes (like the CPV of the Future project based on digital twins). Through these projects, I witnessed firsthand how digital tools can streamline operations, enhance quality control, and drive efficiency. Implementing advanced analytics, machine learning, and automation has not only improved our manufacturing capabilities but also ensured more consistent and reliable outcomes for patients.
Receiving the Distinguished Service Award from PDA is a profound honor that reflects the collective efforts of everyone I have had the privilege to work with. This recognition underscores the importance of our shared mission to harness the power of digitalization to improve drug manufacturing. It also serves as a testament to the transformative impact that collaborative efforts and technological advancements can have on our industry.
Looking back, my journey with PDA has been marked by growth, learning, and meaningful contributions to the pharma community. The support and platform provided by PDA have been instrumental in shaping my career and enabling me to make a tangible difference. As we continue to navigate the ever-evolving landscape of pharmaceutical manufacturing, I remain committed to driving innovation and excellence, inspired by the recognition of this prestigious award and the ongoing opportunities to contribute to our field.
About Toni Manzano
Manzano is the co-founder and CSO of Aizon, a cloud company that provides big data and AI SaaS platforms for the biotech and pharma industries. Manzano is also co-chair of both the Biomanufacturing IG and the CPV of the future initiative at PDA, an active collaborator in the AI initiative for AFDO and he teaches AI subjects at universities (UAB and OBS). Manzano has written numerous articles in the pharma field and holds a dozen international patents related to the encryption, transmission, storage and processing of large volumes of data in regulated environments in the cloud.